Esophagus sarcoma
disease diseaseOn this page
Also known as esophageal sarcomasarcoma of esophagussarcoma of oesophagussarcoma of the esophagussarcoma of the oesophagussarcoma, esophagussarcoma, oesophagus
Summary
Esophagus sarcoma (MONDO:0001204) is a cancer. A subtype of esophageal cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | esophagus sarcoma |
| Mondo ID | MONDO:0001204 |
| DOID | DOID:1114 |
| NCIT | C5341 |
| UMLS | C1333466 |
| MedGen | 234233 |
| GARD | 0022900 |
| Anatomy (UBERON) | UBERON:0001043 |
| Is cancer (heuristic) | yes |
Also known as: esophageal sarcoma · esophagus sarcoma · sarcoma of esophagus · sarcoma of oesophagus · sarcoma of the esophagus · sarcoma of the oesophagus · sarcoma, esophagus · sarcoma, oesophagus
Disease family
This is a subtype of esophageal cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system cancer › esophageal cancer › esophagus sarcoma
Related subtypes (6): esophagus lymphoma, esophageal melanoma, carcinoma of esophagus, malignant neoplasm of abdominal esophagus, malignant neoplasm of thoracic esophagus, malignant neoplasm of cervical esophagus
Subtypes (2): esophagus leiomyosarcoma, esophagus liposarcoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.